3 years ago

Green Bioactives Raises £2.6 Million Seed Funding for Sustainable Biomanufacturing Platform

  • Green Bioactives, a UK-based company focused on commercializing plant vascular stem cells, secured £2.6 million in seed funding

  • Led by Eos Advisory LLP, the round also saw participation from Regenerate Ventures’ Agtech Fund, Milltrust International Group, and Scottish Enterprise

  • Green Bioactives aims to use the funds for team expansion, scaling up its biomanufacturing approach, and continuing research and development

  • The company’s platform utilizes plant vascular stem cells to produce plant biomolecules sustainably for use in cosmetics, pharmaceuticals, food, and agriculture

  • Green Bioactives is currently working with several leading partners in consumer goods, biotechnology, and agriculture to produce high-value bioactives that are difficult to produce sustainably through traditional methods

  • Founded in 2020, Green Bioactives is based at the Roslin Innovation Centre in Edinburgh, Scotland.

      • ProblemTechnology

      "Sustainable production of plant bioactives, like those used in cosmetics, pharmaceuticals, and food, is difficult and expensive. Current methods often rely on unsustainable practices or are economically unviable."

      Solution

      "Green Bioactives uses plant vascular stem cells to create a sustainable and scalable biomanufacturing platform for producing valuable plant bioactives. Their technology allows them to access the vast diversity of plant bioactives and produce them efficiently and sustainably."

      Covered on